Capital increase from authorized capital in connection with the Greenshoe option has been completed

Probiodrug announces the exercise of the Greenshoe Option, increasing the gross proceeds of the Offer to EUR 23.2 million
Probiodrug to present data on therapeutic concept of targeting pyro-Glu Abeta and its frontrunner QC-inhibitor PQ912 at International Alzheimer Conferences